The Targeted Radiopharmaceuticals (TRP) Summit is an industry-led platform, that discusses challenges and opportunities faced by developers of theranostic radio ligand therapies. Topics such as the identification and validation of new targets and ways to improve the current clinical design methodologies will be discussed by speakers and panels.
Entering the 4th year of the Targeted Radiopharmaceuticals EU Summit the flagship event of the TRP series is growing further encompassing critical new topics including:
• applications of software tools in discovery, clinical trials and imaging,
• patient/doctor education.
FIELD-LAB is a drug discovery facility that will help you to speed up the development and market launch of new nuclear drugs for cancer treatment. Through supply of small batches of radio chemicals and radio pharmaceuticals, we meet the need of Bio Pharma scientists and start-up ventures for research materials. This will drive both their ambitions to develop a new drug.
When: Tuesday 6 until Thursday 8, December 2022
If you wish to learn more about the speakers, the programme or registration, please check the TRP Summit website.
If you want to get in touch about the TRP Summit or want to learn more about FIELD-LAB and Advancing Nuclear Medicine, please leave your contact information in this form. We will reach out to you as soon as possible.